Dae, Asmeya M.
HRN: 23-90-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
10/18/2023
10/20/2023
PO
5ml
BID
Intestinal Parasitism
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes